Diabetic Nephropathy News and Research

RSS
Diabetic nephropathy is kidney disease or damage that results as a complication of diabetes.
NOXXON commences NOX-H94 Phase IIa trial to treat anemia of chronic disease

NOXXON commences NOX-H94 Phase IIa trial to treat anemia of chronic disease

Genkyotex announces positive results from GKT137831 Phase I studies on healthy subjects

Genkyotex announces positive results from GKT137831 Phase I studies on healthy subjects

Liver x receptor plays an important role in diabetic nephropathy

Liver x receptor plays an important role in diabetic nephropathy

Data from Genkyotex’s GKT137831 Phase I studies to be presented at Kidney Week 2012

Data from Genkyotex’s GKT137831 Phase I studies to be presented at Kidney Week 2012

Urinary adiponectin as a marker for diabetic nephropathy

Urinary adiponectin as a marker for diabetic nephropathy

NOXXON commences NOX-A12 Phase IIa trial in relapsed MM

NOXXON commences NOX-A12 Phase IIa trial in relapsed MM

PCA inhibits multiple pathways involved in development of diabetic nephropathy

PCA inhibits multiple pathways involved in development of diabetic nephropathy

Age at diabetes onset linked to macular edema onset

Age at diabetes onset linked to macular edema onset

Sleep apnea’s contribution to diabetic nephropathy needs attention

Sleep apnea’s contribution to diabetic nephropathy needs attention

Biopsy required for accurate renal diagnosis in diabetes

Biopsy required for accurate renal diagnosis in diabetes

Low HDL cholesterol ADVANCEs nephropathy risk in diabetes

Low HDL cholesterol ADVANCEs nephropathy risk in diabetes

TWi Pharmaceuticals completes AC-201 phase II study on type II diabetes

TWi Pharmaceuticals completes AC-201 phase II study on type II diabetes

Scientists identify mechanisms by which GLP-1 protects against kidney disease, diabetes

Scientists identify mechanisms by which GLP-1 protects against kidney disease, diabetes

Genkyotex closes CHF25M Series C extension

Genkyotex closes CHF25M Series C extension

Diabetic Neuropathy: An interview with Dr Brian Callaghan

Diabetic Neuropathy: An interview with Dr Brian Callaghan

Bariatric surgery can remit or prevent diabetic nephropathy in obese patients

Bariatric surgery can remit or prevent diabetic nephropathy in obese patients

ChemoCentryx fourth quarter revenues increase to $26.1 million

ChemoCentryx fourth quarter revenues increase to $26.1 million

Concert commences dosing in CTP-499 Phase 2 clinical trial for diabetic nephropathy

Concert commences dosing in CTP-499 Phase 2 clinical trial for diabetic nephropathy

Questcor fourth quarter net sales increase to $75.5 million

Questcor fourth quarter net sales increase to $75.5 million

New biomarkers can predict risk of kidney failure in patients with diabetes

New biomarkers can predict risk of kidney failure in patients with diabetes